Efficacy of 12 weeks oral beta-alanine supplementation in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled trial.
- 2022-08-17
- RCT · n = 40
- Journal of cachexia, sarcopenia and muscle 13(5)
- Jana De Brandt
- Wim Derave
- Frank Vandenabeele
- Pascal Pomiès
- Laura Blancquaert
- Charly Keytsman
- Marina S Barusso-Grüninger
- Fabiano F de Lima
- Maurice Hayot
- Martijn A Spruit
- Chris Burtin
- PubMed: 35977911
- DOI: 10.1002/jcsm.13048
- High evidence
- Clinical
No change was observed in secondary outcomes.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 3.2 g/day